Levetiracetam Aurobindo (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A in the brain, which modulates neurotransmitter release. This action stabilizes neuronal activity, lowers excessive excitability, and prevents the rapid spread of electrical discharges that cause seizures.

The specific dose of Levetiracetam Aurobindo is individualized by the prescribing clinician based on the patient’s age, weight, type of seizure, renal function and response to therapy. Patients should follow the exact dosing instructions provided by their healthcare provider.

Levetiracetam is classified as pregnancy category B, indicating that animal studies have not shown risk but there are limited human data. It may be used during pregnancy only if the potential benefit justifies any potential risk. Small amounts are excreted in breast milk; breastfeeding decisions should be made with a physician’s guidance.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and the necessary import documentation.

Compared with older agents such as carbamazepine or valproate, levetiracetam has a relatively simple pharmacokinetic profile, fewer drug‑enzyme interactions, and does not require routine blood‑level monitoring. However, individual response varies, and some patients may experience behavioral changes that are less common with other drugs.

Levetiracetam tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and avoid storing in bathrooms or other humid environments.

Levetiracetam Aurobindo is taken orally, usually as a tablet swallowed whole with a glass of water. It can be taken with or without food, but patients should follow the timing and frequency prescribed by their clinician to maintain consistent blood levels.

Serious adverse reactions, although rare, include severe allergic skin reactions such as Stevens‑Johnson syndrome, significant mood changes like depression or suicidal thoughts, and hematologic disorders such as neutropenia. Patients should seek immediate medical attention if they notice rash, mood swings, or signs of infection.

Levetiracetam is contraindicated in individuals with a known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for patients with severe renal impairment, as dose adjustment may be required, and for those with a history of psychiatric disorders who may be more susceptible to mood‑related side effects.